Literature DB >> 17121875

Epigenetic biomarkers and breast cancer: cause for optimism.

Kala Visvanathan, Saraswati Sukumar, Nancy E Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17121875     DOI： 10.1158/1078-0432.CCR-06-2001

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  5 in total

Review 1.  Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

Authors:  Amy M Dworkin; Tim H-M Huang; Amanda Ewart Toland
Journal:  Semin Cancer Biol       Date:  2009-02-20       Impact factor: 15.707

2.  Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.

Authors:  Asia Asiaf; Shiekh Tanveer Ahmad; Ajaz Ahmad Malik; Shiekh Aejaz Aziz; Zubaida Rasool; Akbar Masood; Mohammad Afzal Zargar
Journal:  Tumour Biol       Date:  2015-03-29

3.  A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.

Authors:  Qing Xu; Yue Jiang; Yu Yin; Qi Li; Jun He; Yi Jing; Yan-Ting Qi; Qian Xu; Wei Li; Bo Lu; Stephen S Peiper; Bing-Hua Jiang; Ling-Zhi Liu
Journal:  J Mol Cell Biol       Date:  2012-08-29       Impact factor: 6.216

Review 4.  Advances in breast cancer: pathways to personalized medicine.

Authors:  Olufunmilayo I Olopade; Tatyana A Grushko; Rita Nanda; Dezheng Huo
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

5.  NT5E CpG island methylation is a favourable breast cancer biomarker.

Authors:  C Lo Nigro; M Monteverde; S Lee; L Lattanzio; D Vivenza; A Comino; N Syed; A McHugh; H Wang; C Proby; O Garrone; M Merlano; E Hatzimichael; E Briasoulis; O Gojis; C Palmieri; L Jordan; P Quinlan; A Thompson; T Crook
Journal:  Br J Cancer       Date:  2012-05-31       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.